Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

在《新英格兰医学杂志》上发布的对照研究结论表明，使用Zepbound的患者在经过72周的治疗后体重平均减轻了50磅(约22.8公斤)，而使用Wegovy的患者体重 ...

礼来公司(LLY.US)于上周日宣布，根据一项头对头对比试验的数据，其减肥药物Zepbound在减少腰围等五项减肥指标上优于诺和诺德公司(NVO.US)的Wegovy。

智通财经APP获悉，礼来公司于上周日宣布，根据一项头对头对比试验的数据，其减肥药物Zepbound在减少腰围等五项减肥指标上优于诺和诺德公司的Wegovy。

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...

For the first time, a study in The New England Journal of Medicine is comparing the most popular drugs for weight loss, ...

ABC News chief medical correspondent Dr. Tara Narula breaks down what to know about a new study that says Zepbound may be ...